Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616148 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Implementation of an adherence pharmacy referral protocol for patients taking sacubitril/valsartan.
J Manag Care Spec Pharm
January 2025
Department of Pharmacy, Cleveland Clinic, OH.
Background: Heart failure is a prevalent disease state associated with limitations in function, hospitalization, and death. The 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America guidelines recommend medications including sacubitril/valsartan to decrease morbidity and mortality in patients with heart failure. However, if patients are nonadherent to treatment or experience barriers to care, they will forgo these benefits.
View Article and Find Full Text PDFSpecialty pharmacy services compared with community-based pharmacy services on HIV viral load.
J Am Pharm Assoc (2003)
December 2024
Objectives: People with human immunodeficiency virus (HIV) (PWH) on antiretroviral therapy (ART) with viral load (VL) suppression eliminate the risk of sexual transmission. Many factors including decreased ART adherence and medication access barriers decrease the success of treatment as an HIV prevention strategy. ART access may be enhanced with specialty pharmacy services (SPS), but the impact compared with community-based practices is variably reported.
View Article and Find Full Text PDFIntroduction: The COVID-19 pandemic forced a rapid shift toward virtual modalities for the treatment of depression in primary care.
Methods: Participants were adults 18 years and older with a new episode of depression diagnosed in primary care between March 1, 2020, and May 21, 2021, and moderate-to-severe symptoms of depression at the time of diagnosis (N = 9619). Outcomes were 1) antidepressant medications prescribed and dispensed (referred to as received), as well as adherence to those medications; 2) referrals made to depression-related services and the receipt of those services; and 3) a follow-up visit completed with the diagnosing practitioner regardless of treatment actions.
Exploring Consumer Preferences for Pharmacy Provision of Mifepristone in the Human-centered Design Discovery Phase.
Womens Health Issues
November 2024
Ci3, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois.
Article Synopsis
- The study aimed to understand consumer preferences for obtaining mifepristone for medication abortion through a human-centered design approach involving workshops with participants who have experience with abortion care.
- Participants provided insights on key topics such as logistics, privacy, cost, pharmacist refusal, and follow-up care, highlighting their needs for specific information from different providers.
- The findings suggest a need for further research that incorporates personal experiences and storytelling methods to enhance the understanding of consumer experiences in accessing medication abortion services.
Does the type of pharmacy used influence medication adherence? A retrospective observational study in Aotearoa, New Zealand.
Can Pharm J (Ott)
July 2024
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Background: Community pharmacies in New Zealand have varying ownership and operational structures. Unlike independent pharmacies, corporate and hybrid pharmacies do not charge prescription copayments.
Objectives: This research aimed to determine whether people receiving free prescriptions from corporate and hybrid pharmacies (via copayment waiver) have greater medication adherence than the users of independent pharmacies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!